Success Metrics

Clinical Success Rate
100.0%

Based on 15 completed trials

Completion Rate
100%(15/15)
Active Trials
2(10%)
Results Posted
53%(8 trials)

Phase Distribution

Ph phase_1
4
19%
Ph phase_3
2
10%
Ph phase_2
7
33%
Ph phase_4
4
19%
Ph early_phase_1
1
5%
Ph not_applicable
2
10%

Phase Distribution

5

Early Stage

7

Mid Stage

6

Late Stage

Phase Distribution20 total trials
Early Phase 1First-in-human
1(5.0%)
Phase 1Safety & dosage
4(20.0%)
Phase 2Efficacy & side effects
7(35.0%)
Phase 3Large-scale testing
2(10.0%)
Phase 4Post-market surveillance
4(20.0%)
N/ANon-phased studies
2(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

15 of 18 finished

Non-Completion Rate

16.7%

3 ended early

Currently Active

2

trials recruiting

Total Trials

21

all time

Status Distribution
Active(3)
Completed(15)
Terminated(3)

Detailed Status

Completed15
Withdrawn3
Active, not recruiting1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (5.0%)
Phase 14 (20.0%)
Phase 27 (35.0%)
Phase 32 (10.0%)
Phase 44 (20.0%)
N/A2 (10.0%)

Trials by Status

withdrawn314%
completed1571%
active_not_recruiting15%
not_yet_recruiting15%
recruiting15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT05975580Phase 4

Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery

Recruiting
NCT07282340Phase 2

Phentermine's Impact on Treatment in Teens

Not Yet Recruiting
NCT05756764

Anti-obesity Pharmacotherapy and Inflammation

Active Not Recruiting
NCT04572217Phase 2

Medications After Adolescent Bariatric Surgery

Withdrawn
NCT04095104Phase 2

Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds

Completed
NCT01950520Phase 2

Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate

Completed
NCT05215418Phase 4

A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects

Completed
NCT03374956Phase 3

Individualized Obesity Pharmacotherapy

Completed
NCT00771654Not Applicable

Phentermine/Gastric Band Weight Loss Study

Withdrawn
NCT01616082Not Applicable

Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)

Completed
NCT03849729Phase 4

Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery

Completed
NCT02239913Phase 1

Topiramate-Phentermine Combinations for Cocaine Dependence

Completed
NCT03152123Phase 1

Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users

Completed
NCT01886937Phase 4

Studying the Effects of Phentermine on Eating Behavior

Completed
NCT02243202Phase 2

Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants

Completed
NCT01719185Early Phase 1

The Effect of Phentermine and B12 on Weight Loss Among Obese Patients

Completed
NCT00563368Phase 3

A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults

Completed
NCT00402077Phase 2

A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Completed
NCT00000506Phase 2

Cardiovascular System in Obesity: Effect of Treatment

Completed
NCT01500018Phase 1

Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214

Withdrawn

Drug Details

Intervention Type
DRUG
Total Trials
21